Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-11-15 ROBIN HOWARD W President & CEO Grant or award · Stock Option +137,500 137,500
2017-11-15 Nicholson John SVP & Chief Operating Officer Grant or award +20,000 253,156
2017-11-15 Nicholson John SVP & Chief Operating Officer Grant or award · Stock Option +50,000 50,000
2017-11-15 Labrucherie Gil M SVP & Chief Financial Officer Grant or award +20,000 83,414
2017-11-15 Labrucherie Gil M SVP & Chief Financial Officer Grant or award · Stock Option +50,000 50,000
2017-11-15 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award +15,000 73,233
2017-11-15 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award · Stock Option +37,500 37,500
2017-11-15 Gergel Ivan P. SVP & Chief Medical Officer Grant or award +20,000 61,575
2017-11-15 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Stock Option +50,000 50,000
2017-11-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award +17,500 48,602
2017-11-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +43,750 43,750
2017-11-13 Nicholson John SVP & Chief Operating Officer Exercise or conversion +25,000 $9.24 $231K 249,066
2017-11-13 Nicholson John SVP & Chief Operating Officer Sale −15,910 $37.78 $601K 233,156
2017-11-13 Nicholson John SVP & Chief Operating Officer Exercise or conversion · Stock Option −25,000 0
2017-11-08 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +300,000 $9.53 $2.9M 331,102
2017-11-08 Doberstein Stephen K SVP & Chief Scientific Officer Sale −300,000 $30.09 $9.0M 31,102
2017-11-08 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion · Stock Option −300,000 0
2017-11-07 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion +17,300 $10.69 $185K 75,533
2017-11-07 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion −17,300 $25.51 $441K 58,233
2017-11-07 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion · Stock Option −17,300 0

Page 38 of 43 · 847 trades